New Leaf Venture Partners, L.L.C.

New Leaf Venture Partners, L.L.C. latest Q4_2020 13F filings reported $432,816,000 in market value on this 2021-02-10 report date . The portfolio quarterly return is 74.39%. This fund has 17 securities concentrations of 100% weights.

New Leaf Venture Partners, L.L.C. largest holding is Arvinas Inc. with weight of 44.80% and $193,899,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.

Portfolio Performance History

FILE DATEREPORT PERIODQTR YEARFILE TYPENOS. OF STOCKSREPORTED VALUERETURN
2021-02-102020-12-31Q4_202013F-HR17$432,816,00074.39%
2020-11-122020-09-30Q3_202013F-HR18$248,188,000-28.78%
2020-08-132020-06-30Q2_202013F-HR20$348,503,0004.25%
2020-05-142020-03-31Q1_202013F-HR20$334,291,000-27.37%
2020-02-132019-12-31Q4_201913F-HR19$460,293,00039.22%
2019-11-142019-09-30Q3_201913F-HR19$330,614,000-11.38%
2019-08-132019-06-30Q2_201913F-HR21$373,081,0002.23%
2019-06-042019-03-31Q1_201913F-HR/A20$364,942,0000.00%
2019-05-152019-03-31Q1_201913F-HR20$359,521,000-1.31%
2019-02-132018-12-31Q4_201813F-HR20$364,301,000-33.71%
2018-11-132018-09-30Q3_201813F-HR20$549,556,00032.64%
2018-08-142018-06-30Q2_201813F-HR15$414,327,000123.73%
2018-05-152018-03-31Q1_201813F-HR14$185,189,000-13.39%
2018-02-142017-12-31Q4_201713F-HR16$213,809,000-0.78%
2017-11-142017-09-30Q3_201713F-HR16$215,484,00051.36%
2017-08-142017-06-30Q2_201713F-HR15$142,363,000-27.07%
2017-05-152017-03-31Q1_201713F-HR16$195,197,00039.81%
2017-02-142016-12-31Q4_201613F-HR15$139,613,0000.51%
2016-11-142016-09-30Q3_201613F-HR14$138,901,00019.50%
2016-08-152016-06-30Q2_201613F-HR14$116,235,0005.19%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightComputed PriceShares Change %Current Shares
ARVINAS INCARVNINCR$193,8992.60%44.80%$84.930.00%2,283,048
DECIPHERA PHARMACEUTICALS INDCPHINCR$69,0300.11%15.95%$57.070.00%1,209,571
PASSAGE BIO INCPASGINCR$63,8720.95%14.76%$25.570.00%2,497,922
HARPOON THERAPEUTICS INCHARPDECR$48,525-0.02%11.21%$16.610.00%2,921,405
APTINYX INCAPTXINCR$11,3840.02%2.63%$3.460.00%3,290,079
Sierra Oncology, IncINCR$6,5660.50%1.52%$16.030.00%409,611
CHIMERIX INCCMRXINCR$6,5210.94%1.51%$4.830.00%1,350,000
COGENT BIOSCIENCES INCCOGTBUY$5,4960.00%1.27%$11.230.00%489,380
ARAVIVE INCARAVINCR$5,3380.20%1.23%$5.640.00%946,423
ALECTOR INCALECINCR$5,1380.44%1.19%$15.130.00%339,569
CHIASMA INCCHMAINCR$4,9400.01%1.14%$4.350.00%1,135,700
AVROBIO INCAVROINCR$4,3990.07%1.02%$13.940.00%315,550
X4 PHARMACEUTICALS INCXFORDECR$2,154-0.05%0.50%$6.430.00%335,000
CRINETICS PHARMACEUTICALS INCRNXDECR$1,990-0.10%0.46%$14.110.00%141,000
OBSEVA SAOBSVDECR$1,873-0.16%0.43%$2.080.00%900,501
ITERUM THERAPEUTICS PLCITRMDECR$1,440-0.06%0.33%$0.990.00%1,456,303
PDS BIOTECHNOLOGY CORPORATION COMPDSBDECR$251-0.08%0.06%$2.140.00%117,242
MINERVA NEUROSCIENCES INCNERVSOLD$00.00%-100.00%$0.000.00%0
UNUM THERAPEUTICS INCUNUMSOLD$00.00%-100.00%$0.000.00%0